Recombinant Protochlamydia amoebophila 50S ribosomal protein L32 (rpmF)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is finalized during production. If a specific tag type is required, please inform us for preferential development.
Synonyms
rpmF; pc1315; 50S ribosomal protein L32
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-60
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Protochlamydia amoebophila (strain UWE25)
Target Names
rpmF
Target Protein Sequence
MAVPRNRLSN ARKNSKRAHH AKKPKSLSIC SNCGTARLPH CSCKACGTYA DRTPTTQEAQ
Uniprot No.

Q&A

What is Protochlamydia amoebophila and why is its 50S ribosomal protein L32 significant?

Protochlamydia amoebophila belongs to the phylum Chlamydiae, which consists exclusively of obligate intracellular bacteria. Unlike human pathogens such as Chlamydia trachomatis, P. amoebophila typically functions as a symbiont of amoebae . The 50S ribosomal protein L32 (rpmF) is a critical component of the large ribosomal subunit essential for protein synthesis in bacteria. Its significance stems from several factors: it plays a crucial role in ribosome assembly and function, it may contribute to the unusual biology of P. amoebophila, and it represents a potential target for comparative studies between different chlamydial species. Of particular interest is P. amoebophila's remarkable ability to remain metabolically active outside its host cell for extended periods (up to 3 weeks), during which it continues to perform protein synthesis . This extracellular activity challenges traditional understandings of obligate intracellular bacteria and suggests specialized adaptations in its translational machinery, including ribosomal proteins like rpmF.

How does P. amoebophila rpmF compare structurally to homologous proteins in other bacteria?

While specific structural data for P. amoebophila rpmF is limited in the current literature, meaningful comparisons can be made with better-characterized bacterial L32 proteins such as those from E. coli. The E. coli 50S ribosomal protein L32 consists of 57 amino acids with the sequence AVQQNKPTRSKRGMRRSHDALTAVTSLSVDKTSGEKHLRHHITADGYYRGRKVIAK . When expressed recombinantly with a GST tag, it has a molecular weight of approximately 33.3kDa .

Ribosomal proteins are generally highly conserved in functionally critical regions while showing variation in other domains. The L32 protein typically contains:

  • Basic residues important for rRNA interactions

  • A compact fold that fits within the complex ribosomal architecture

  • Specific interaction surfaces for neighboring ribosomal components

P. amoebophila rpmF likely maintains core structural elements essential for ribosome function while potentially possessing unique adaptations related to its unusual biology, including ability to function in both intracellular and extended extracellular environments .

What expression systems are recommended for producing recombinant P. amoebophila rpmF?

Based on established protocols for similar ribosomal proteins, an E. coli expression system represents the most practical approach for producing recombinant P. amoebophila rpmF . The following expression strategy is recommended:

Expression System Components:

  • Vector: pGEX series for GST fusion (enhances solubility) or pET series for His-tagged protein

  • Host strain: BL21(DE3) or Rosetta (DE3) for rare codon optimization

  • Induction: 0.1-0.5 mM IPTG at mid-log phase (OD600 ~0.6-0.8)

  • Growth conditions: Post-induction expression at 18-25°C to improve protein solubility

Purification Approach:

  • Affinity chromatography (GST or His-tag based)

  • Optional tag cleavage (if required for downstream applications)

  • Size exclusion chromatography for final purification

  • Storage in Tris/PBS-based buffer with 5-50% glycerol at -20°C/-80°C

This approach mimics successful strategies used for other ribosomal proteins while addressing potential solubility challenges. The fusion tag approach is particularly beneficial as ribosomal proteins may have solubility issues when expressed independently of their natural ribosomal context.

What are the optimal storage conditions for maintaining stability of recombinant P. amoebophila rpmF?

Maintaining stability of recombinant P. amoebophila rpmF requires careful attention to storage conditions. Based on protocols for similar recombinant ribosomal proteins, the following guidelines are recommended:

Short-term storage (up to one week):

  • Store working aliquots at 4°C in appropriate buffer

  • Avoid repeated freeze-thaw cycles that can cause protein degradation

Long-term storage:

  • Store at -20°C/-80°C in aliquots to prevent repeated freezing and thawing

  • Include 5-50% glycerol in storage buffer to prevent freeze damage

Alternative storage option:

  • Lyophilization in Tris/PBS-based buffer containing 6% Trehalose at pH 8.0

  • Store lyophilized powder at -20°C

  • Reconstitute in deionized sterile water to 0.1-1.0 mg/mL concentration

When reconstituting lyophilized protein, briefly centrifuge the vial before opening to ensure all material is at the bottom . For proteins intended for functional studies, the addition of glycerol to a final concentration of 5-50% after reconstitution is recommended .

How can Raman microspectroscopy be applied to study recombinant P. amoebophila rpmF structure and function?

Raman microspectroscopy offers valuable approaches for studying recombinant P. amoebophila rpmF, particularly given its successful application to intact P. amoebophila for distinguishing between developmental stages and tracking metabolic activity . This non-destructive analytical technique provides information about molecular vibrations and chemical bonds, enabling characterization of protein secondary structure, dynamics, and interactions.

Methodological approach:

  • Sample preparation: Purified recombinant rpmF in appropriate buffer at 1-5 mg/mL

  • Spectral acquisition: Using confocal Raman microspectroscopy with 532 nm or 785 nm laser excitation

  • Comparative analysis: Between different conditions (native vs. denatured, free vs. RNA-bound)

  • Isotope labeling: Incorporation of isotope-labeled amino acids (e.g., 13C-phenylalanine) for tracking specific residues, similar to the approach used in whole-cell P. amoebophila studies

Applications for rpmF studies:

  • Monitoring conformational changes upon binding to rRNA

  • Investigating structural stability under various environmental conditions

  • Tracking changes in labeled amino acids over time to assess protein dynamics

  • Comparing recombinant protein structure to native protein where possible

This technique is particularly valuable because it allows analysis of proteins in solution without requiring crystallization, providing insights into physiologically relevant conformational states.

What analytical techniques are most effective for studying interactions between P. amoebophila rpmF and ribosomal RNA?

Investigating the interactions between P. amoebophila rpmF and ribosomal RNA requires specialized techniques that can detect and characterize protein-RNA binding. Several complementary approaches are recommended:

Electrophoretic Mobility Shift Assay (EMSA):

  • Incubate purified rpmF with fluorescently labeled rRNA fragments

  • Analyze on native PAGE to visualize mobility shifts

  • Quantify band intensities to determine binding affinity constants

  • Include competition assays with unlabeled RNA to assess specificity

Surface Plasmon Resonance (SPR):

  • Immobilize either rpmF or RNA on sensor chip

  • Measure real-time association and dissociation kinetics

  • Determine binding constants (kon, koff, KD) under various buffer conditions

  • Assess effects of mutations or modifications on binding

Isothermal Titration Calorimetry (ITC):

  • Directly measure thermodynamic parameters of binding

  • Determine enthalpy, entropy, and binding stoichiometry

  • No labeling required, providing data in solution state

Fluorescence-based methods:

  • Fluorescence anisotropy to monitor changes upon RNA binding

  • FRET assays if appropriate fluorophore pairs can be incorporated

These techniques should be used in combination to provide a comprehensive characterization of the rpmF-rRNA interaction, including affinity, specificity, kinetics, and thermodynamics.

How can researchers optimize purification protocols for recombinant P. amoebophila rpmF?

Optimizing purification of recombinant P. amoebophila rpmF requires addressing several challenges common to ribosomal proteins, including potential solubility issues and maintaining native structure. The following multi-step purification strategy is recommended:

Step 1: Cell lysis optimization

  • Buffer composition: 50 mM Tris-HCl, pH 7.5-8.0, 150-300 mM NaCl, 1 mM DTT

  • Addition of lysozyme (1 mg/mL) and DNase I (5 μg/mL)

  • Gentle lysis via sonication with cooling between pulses

  • Clarification by high-speed centrifugation (≥20,000 × g for 30 min)

Step 2: Affinity chromatography

  • For GST-tagged protein: Glutathione Sepharose with elution using reduced glutathione

  • For His-tagged protein: Ni-NTA resin with imidazole gradient elution

  • Include reducing agent (1-5 mM DTT or 1-2 mM β-mercaptoethanol) in all buffers

Step 3: Tag removal (if required)

  • For GST-fusion: PreScission protease cleavage

  • For His-tag: TEV protease cleavage

  • Performed during dialysis to remove initial elution buffer

Step 4: Secondary purification

  • Ion exchange chromatography (likely cation exchange given the basic nature of ribosomal proteins)

  • Size exclusion chromatography to remove aggregates and achieve final purity

Step 5: Quality control

  • SDS-PAGE to verify purity (target >90%)

  • Mass spectrometry to confirm protein identity

  • Dynamic light scattering to assess homogeneity

  • Activity assays (e.g., RNA binding) to confirm functionality

This protocol should be optimized iteratively, with particular attention to buffer composition, salt concentration, and pH at each step to maximize yield and maintain protein stability.

What approaches can be used to study the potential self-assembly of recombinant P. amoebophila rpmF?

Based on observations of unusual self-assembly behavior in other recombinant chlamydial proteins such as the C. trachomatis MOMP-based fusion antigen CTH522 , investigating potential self-assembly of recombinant P. amoebophila rpmF is important. Several complementary techniques are recommended:

Dynamic Light Scattering (DLS):

  • Measures hydrodynamic radius to detect oligomers or higher-order assemblies

  • Can monitor size distribution as a function of concentration, pH, or temperature

  • Provides data on polydispersity and potential aggregation

Size Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS):

  • Separates different oligomeric species

  • Provides absolute molecular weight of each species

  • Allows quantification of distribution between monomers and various oligomers

Transmission Electron Microscopy (TEM):

  • Direct visualization of any nanoparticles or higher-order structures

  • Negative staining to enhance contrast

  • Analysis of particle size distribution and morphology

Analytical Ultracentrifugation (AUC):

  • Sedimentation velocity experiments to determine size distribution

  • Sedimentation equilibrium to determine association constants

  • Can distinguish between different assembly models

Zeta Potential Measurements:

  • Characterize surface charge of any self-assembled structures (similar to the negative zeta potential observed with CTH522)

  • Provide insights into stability and potential interactions

The CTH522 study noted that native protein did not exist as monomers but self-assembled into nanoparticles, with a structure maintained through hydrophobic interactions that could be disrupted by denaturants but reformed upon their removal . Similar behavior in P. amoebophila rpmF would have significant implications for handling, storage, and functional studies.

How can RP-HPLC be optimized for quantitative analysis of recombinant P. amoebophila rpmF?

Reversed-phase high-performance liquid chromatography (RP-HPLC) can be effectively adapted for quantitative analysis of recombinant P. amoebophila rpmF. Drawing from established bioanalytical RP-HPLC methodologies , the following optimization strategy is recommended:

Chromatographic Conditions:

  • Column selection: C18 reversed-phase column (e.g., Zorbax SB-C18)

  • Mobile phase composition: Gradient of water with 0.2% acetic acid (v/v) and acetonitrile

  • Flow rate: 0.5 mL/min with adjustment based on column dimensions

  • Column temperature: Controlled at 25-30°C for reproducibility

  • Detection: UV absorbance at 214 nm (peptide bonds) and 280 nm (aromatic amino acids)

Method Development Process:

  • Initial scouting runs: Test different mobile phase compositions (40-60% organic phase)

  • Gradient optimization: Adjust slope and duration to achieve optimal peak resolution

  • Sample preparation protocol: Standardize protein concentration and buffer components

  • Calibration curve development: Prepare standards covering 0.5-10 μg range

  • Validation: Assess linearity, precision, accuracy, LOD, LOQ, and specificity

Sample Preparation Considerations:

  • Centrifuge samples briefly before injection to remove particulates

  • Use identical buffer composition for standards and samples

  • Include control proteins of known concentration for system suitability

Method Validation Parameters:

  • Linearity: R² > 0.995 across working range

  • Precision: RSD < 2% for intra-day and < 5% for inter-day measurements

  • Accuracy: 95-105% recovery

  • Specificity: Resolution > 1.5 between rpmF and potential contaminants

This optimized RP-HPLC method would provide a reliable approach for quantifying recombinant P. amoebophila rpmF in various experimental contexts, such as expression optimization, stability studies, or interaction assays.

How does P. amoebophila's unusual extracellular activity influence approaches to studying its ribosomal proteins?

The remarkable discovery that P. amoebophila remains metabolically active and capable of protein synthesis outside its host for up to three weeks has profound implications for research on its ribosomal proteins, including rpmF. This unique capability suggests specialized adaptations in the translational machinery that differentiate it from typical obligate intracellular bacteria.

Research implications:

  • Environmental adaptability: P. amoebophila ribosomes likely function across a wider range of conditions than those of strictly intracellular pathogens, suggesting potential structural adaptations in ribosomal proteins like rpmF.

  • Membrane energization: The ability to energize its membrane extracellularly indicates that P. amoebophila maintains essential physiological functions including ATP generation necessary for protein synthesis, suggesting an interconnection between energy metabolism and ribosome function.

  • Protein synthesis during stress: P. amoebophila performs protein synthesis under extracellular conditions , which likely represents a stress response. This parallels observations in C. trachomatis, which synthesizes stress-related proteins during extended extracellular incubation .

Methodological approaches:

  • Study rpmF function under both standard and stress conditions to understand its potential role in adaptation

  • Compare recombinant rpmF activity at different temperatures, pH values, and ionic strengths

  • Investigate potential post-translational modifications that might regulate rpmF function during stress

  • Examine rpmF interactions with stress-response factors or specialized regulatory RNAs

These unusual biological characteristics make P. amoebophila an excellent model for studying how ribosomal proteins contribute to bacterial adaptation and survival under challenging conditions, potentially revealing novel functions beyond their canonical role in translation.

What techniques can be used to study potential post-translational modifications of P. amoebophila rpmF?

Post-translational modifications (PTMs) can significantly impact protein function, and ribosomal proteins are known to undergo various modifications. For P. amoebophila rpmF, a comprehensive analysis of potential PTMs requires integrated analytical approaches:

Mass Spectrometry-Based Methods:

  • Bottom-up approach:

    • Enzymatic digestion (trypsin, chymotrypsin) of purified rpmF

    • LC-MS/MS analysis of resulting peptides

    • Database searching with variable modification parameters

    • Manual validation of modified spectra

  • Top-down approach:

    • Direct analysis of intact protein by high-resolution MS

    • Determination of accurate mass to identify modifications

    • MS/MS fragmentation to localize modification sites

    • Particularly useful for mapping combinations of modifications

Enrichment Strategies for Specific PTMs:

  • Phosphorylation: Metal oxide affinity chromatography (MOAC) or immunoprecipitation with phospho-specific antibodies

  • Methylation/Acetylation: Antibody-based enrichment

  • Glycosylation: Lectin affinity chromatography

Validation Techniques:

  • Site-directed mutagenesis of identified modification sites

  • Western blotting with modification-specific antibodies

  • Functional assays comparing modified and unmodified protein

  • Structural studies to assess impact on conformation

Comparative Analysis:

  • Compare PTM profiles between recombinant protein and native protein (if accessible)

  • Examine PTM differences between standard and stress conditions

  • Compare P. amoebophila rpmF modifications with those of homologous proteins from other bacteria

Understanding the PTM landscape of P. amoebophila rpmF would provide insights into potential regulatory mechanisms that might contribute to its function during both intracellular and extracellular phases of the bacterial life cycle.

What are the most effective isotope labeling strategies for structural studies of recombinant P. amoebophila rpmF?

Isotope labeling is essential for advanced structural studies of proteins using techniques such as NMR spectroscopy. For recombinant P. amoebophila rpmF, several labeling strategies can be employed, drawing inspiration from the isotope labeling approaches used in studies of P. amoebophila :

Uniform Labeling Approaches:

  • 15N labeling:

    • Express protein in minimal media with 15NH4Cl as sole nitrogen source

    • Enables acquisition of 1H-15N HSQC spectra for structural fingerprinting

    • Suitable for monitoring protein-RNA interactions by chemical shift perturbations

  • 13C/15N double labeling:

    • Grow expression host in media containing both 15NH4Cl and 13C-glucose

    • Allows for acquisition of triple-resonance NMR experiments

    • Essential for complete backbone and side-chain assignments

  • Deuteration strategies:

    • Expression in D2O-based media for partial or complete deuteration

    • Reduces spectral complexity and improves relaxation properties

    • Particularly valuable for larger protein constructs or complexes

Selective Labeling Approaches:

  • Amino acid-specific labeling:

    • Similar to the isotope-labeled phenylalanine approach used in P. amoebophila studies

    • Particularly useful for probing specific regions of interest

    • Can be combined with selective unlabeling of other residues

  • Segmental labeling:

    • For larger constructs where domains need to be studied separately

    • Requires protein splicing or chemical ligation techniques

    • Reduces spectral complexity for targeted analyses

Implementation Protocol:

  • Transform expression plasmid into appropriate E. coli strain

  • Establish growth in rich media, then transfer to minimal media containing isotope sources

  • Induce expression at lower temperatures (18-25°C) to maximize proper folding

  • Purify using standard protocols with attention to maintaining native structure

  • Verify incorporation rate by mass spectrometry before structural studies

These isotope labeling approaches would enable detailed structural characterization of recombinant P. amoebophila rpmF and its interactions with RNA and other ribosomal components.

How can researchers investigate the functional role of P. amoebophila rpmF in ribosome assembly?

Understanding the role of P. amoebophila rpmF in ribosome assembly requires specialized approaches that can track its incorporation and function within the complex ribosomal architecture:

In vitro Reconstitution Studies:

  • Prepare core ribosomal components (rRNA and essential proteins)

  • Add purified recombinant rpmF at different stages of assembly

  • Monitor assembly progression using:

    • Sedimentation analysis to track formation of intermediate and mature particles

    • Cryo-electron microscopy to visualize structural changes

    • Activity assays to assess functional competence at each stage

Binding Site Mapping:

  • RNA footprinting: Treat rpmF-rRNA complexes with ribonucleases or chemical probes

  • Cross-linking studies: Use UV or chemical cross-linkers followed by mass spectrometry

  • SHAPE analysis: Examine rRNA structural changes upon rpmF binding

Assembly Hierarchy Determination:

  • Design sequential addition experiments with other ribosomal proteins

  • Identify cooperative or competitive binding relationships

  • Compare with established assembly maps from model organisms

Mutational Analysis:

  • Generate targeted mutations in conserved or unique regions of rpmF

  • Assess impact on:

    • Binding affinity to rRNA and other ribosomal proteins

    • Assembly progression and kinetics

    • Structural integrity of resulting ribosomes

    • Translational activity of reconstituted particles

Comparative Approaches:

  • Parallel studies with E. coli L32 to identify conserved assembly functions

  • Investigation of potential adaptations related to P. amoebophila's unusual extracellular activity

These approaches would provide comprehensive insights into both the conserved functions of rpmF in ribosome assembly and any specialized adaptations in P. amoebophila that might contribute to its remarkable biological capabilities.

What are the most significant challenges when working with recombinant P. amoebophila ribosomal proteins and how can they be addressed?

Working with recombinant P. amoebophila ribosomal proteins presents several significant challenges that require specialized approaches. Based on experiences with similar proteins, including those from related organisms, the following challenges and solutions are particularly relevant:

Challenge 1: Protein Solubility and Stability

  • Issue: Ribosomal proteins often have positively charged regions for RNA binding that can promote aggregation

  • Solutions:

    • Use solubility-enhancing fusion partners (GST, MBP)

    • Express at lower temperatures (16-20°C)

    • Include stabilizing agents (glycerol, arginine) in buffers

    • Develop custom buffer systems through systematic screening

    • Consider co-expression with binding partners or chaperones

Challenge 2: Structural Integrity Outside Ribosomal Context

  • Issue: Many ribosomal proteins adopt their native conformation only within the ribosome

  • Solutions:

    • Include binding RNA fragments during purification

    • Optimize buffer conditions to mimic the ribosomal environment

    • Validate structure using biophysical techniques

    • Address potential self-assembly behavior similar to that observed in other chlamydial proteins

Challenge 3: Functional Characterization

  • Issue: Isolating single functions is difficult since ribosomal proteins act in a complex network

  • Solutions:

    • Develop partial reconstitution systems

    • Create chimeric proteins with well-characterized domains

    • Establish in vitro translation systems to test functionality

    • Use comparative approaches with model organism homologs

Challenge 4: Expression Host Limitations

  • Issue: E. coli may lack specific factors needed for proper processing/modification

  • Solutions:

    • Compare recombinant protein to native protein where possible

    • Consider alternative expression hosts

    • Perform post-purification modifications if necessary

    • Implement MS-based approaches to identify missing modifications

Challenge 5: Reproducing Environmental Adaptations

  • Issue: Recreating conditions that mimic P. amoebophila's extracellular activity

  • Solutions:

    • Develop buffer systems that mimic extracellular environment

    • Test protein function across broader ranges of conditions

    • Include stress factors known to be present during extracellular survival

    • Design experiments to compare intracellular and extracellular conditions

Addressing these challenges requires an integrated approach combining proper expression system selection, optimized purification protocols, and specialized functional assays that account for the unique biology of P. amoebophila.

How does P. amoebophila rpmF compare with rpmF from pathogenic Chlamydia species, and what are the research implications?

Comparing P. amoebophila rpmF with its counterparts in pathogenic Chlamydia species (such as C. trachomatis) provides valuable insights into both evolutionary relationships and functional adaptations. These comparisons have significant implications for understanding chlamydial biology and potentially for therapeutic development.

Evolutionary Context:

  • P. amoebophila represents an environmental chlamydial lineage, while C. trachomatis has evolved as a human pathogen

  • Both belong to the same phylum (Chlamydiae) but have adapted to different hosts and lifestyles

  • Comparing their ribosomal proteins can reveal conserved core functions versus specialized adaptations

Functional Differences:

  • Both organisms can perform protein synthesis extracellularly, but P. amoebophila remains infective for a remarkably extended period (up to 3 weeks)

  • C. trachomatis synthesizes specific stress-related proteins during extracellular incubation

  • These differences suggest potential variation in how ribosomal proteins like rpmF may function under stress conditions

Research Implications:

  • Therapeutic targeting: Identifying unique features of pathogenic Chlamydia rpmF could enable selective targeting without affecting environmental species

  • Understanding persistence: Comparative studies could reveal mechanisms of long-term survival relevant to persistent infections

  • Host adaptation: Differences may reveal how ribosomal proteins adapt to different host environments

  • Evolutionary insights: Analysis could contribute to understanding chlamydial evolution and host range determination

Methodological Approach:

  • Parallel expression and characterization of rpmF from both species

  • Comparative structural studies (CD spectroscopy, thermal stability, crystal structures if possible)

  • Cross-functionality experiments (can one protein substitute for the other?)

  • Examination of binding properties to conserved vs. species-specific rRNA sequences

This comparative approach would provide valuable insights into both fundamental aspects of ribosomal function and the specialized adaptations that contribute to the distinct biological characteristics of these related but differently adapted bacteria.

What insights can structural studies of P. amoebophila rpmF provide for antibiotic development?

Structural studies of P. amoebophila rpmF can provide valuable insights for antibiotic development, particularly given the continued need for new antimicrobials against chlamydial infections. While P. amoebophila itself is not a human pathogen, its study offers several advantages in this context:

Ribosomal Proteins as Antibiotic Targets:

  • The bacterial ribosome is a major target for antibiotics (macrolides, aminoglycosides, tetracyclines)

  • Ribosomal proteins can directly interact with antibiotics or influence binding sites

  • Understanding structural features of rpmF could reveal potential binding pockets or interaction surfaces

Comparative Framework for Drug Development:

  • P. amoebophila can be safely manipulated without the biosafety concerns of pathogenic chlamydiae

  • Its extended extracellular viability makes it an excellent model for studying antibiotic effects

  • Structural information can guide development of compounds targeting pathogenic relatives

Research Strategies:

  • High-resolution structure determination:

    • X-ray crystallography or cryo-EM of rpmF alone and in ribosomal context

    • Identification of unique structural features compared to host ribosomes

    • Mapping of potential binding sites for small molecules

  • Structure-based drug design:

    • In silico screening against identified binding pockets

    • Fragment-based approaches to identify starting compounds

    • Development of targeted libraries based on structural insights

  • Validation studies:

    • Binding assays with candidate compounds

    • Co-crystallization with promising inhibitors

    • Functional studies to confirm mechanism of action

  • Translation to pathogenic species:

    • Testing of identified compounds against C. trachomatis

    • Structure-activity relationship studies to optimize selectivity

    • Evaluation of effectiveness against persistent forms

The unusual capability of P. amoebophila to perform protein synthesis extracellularly offers a unique opportunity to study antibiotic effects on an isolated translation system without the confounding effects of host cells, potentially accelerating the identification of novel ribosome-targeting antimicrobials.

What is known about the role of rpmF in the extracellular survival and activity of P. amoebophila?

Established Extracellular Activities of P. amoebophila:

  • Uptake of isotope-labeled amino acids (phenylalanine) during extracellular incubation

  • Membrane energization outside of host cells

  • Protein synthesis in the extracellular environment

  • Maintenance of infectivity for extended periods

Potential Roles of rpmF in These Processes:

  • Structural stability of ribosomes: rpmF may contribute to ribosome integrity under extracellular conditions

  • Specialized translation: Potentially involved in selective translation of stress-response proteins

  • Adaptation to changing environments: May undergo modifications or conformational changes to optimize ribosome function outside host cells

  • Potential non-canonical functions: Some ribosomal proteins have secondary roles beyond translation

Research Questions to Address:

  • Does rpmF undergo structural or modification changes during extracellular transition?

  • Is the expression level of rpmF altered during extracellular maintenance?

  • Does rpmF interact with specific stress-response factors outside the ribosome?

  • Would modification of rpmF affect the duration of extracellular viability?

Methodological Approaches:

  • Comparative proteomic analysis of intracellular vs. extracellular P. amoebophila

  • Immunolocalization studies to track rpmF distribution under different conditions

  • Protein-protein interaction studies to identify extracellular binding partners

  • Expression of tagged rpmF for in vivo tracking during host-free periods

Understanding the role of rpmF in extracellular survival would contribute significantly to our knowledge of chlamydial biology and potentially reveal novel mechanisms for bacterial persistence outside host cells.

How might the unusual self-assembly behavior observed in other chlamydial proteins apply to P. amoebophila rpmF?

The unusual self-assembly behavior reported for the Chlamydia trachomatis MOMP-based fusion antigen CTH522 suggests that similar phenomena might occur with P. amoebophila rpmF, with significant implications for research approaches and interpretations.

Characteristics of CTH522 Self-Assembly:

  • In its native state, CTH522 does not exist as a monomer but self-assembles into nanoparticles

  • These nanoparticles display a negative zeta potential

  • The protein lacks well-defined secondary structural elements despite self-assembly

  • Chemical unfolding produces monomers that reassemble upon denaturant removal

  • The self-assembled structure contains elements stabilized by hydrophobic interactions

Potential Implications for P. amoebophila rpmF:

  • Structural analysis challenges: Traditional structural methods assuming monomeric proteins may need adaptation

  • Functional considerations: Self-assembly could represent a functional state rather than an artifact

  • Purification strategy impact: Self-assembly may influence choice of purification methods and buffer conditions

  • Storage and handling: Aggregation state may affect long-term stability and experimental reproducibility

Experimental Design Recommendations:

  • Characterization of assembly state:

    • Dynamic light scattering to determine size distribution

    • Analytical ultracentrifugation to establish oligomerization state

    • Negative-stain electron microscopy to visualize any particles

    • Zeta potential measurements to characterize surface properties

  • Stability assessment:

    • Chemical denaturation studies to determine if monomers can be isolated

    • Refolding experiments to assess reassembly behavior

    • Temperature and pH stability of assembled structures

  • Functional implications:

    • Comparison of biological activity between different assembly states

    • Analysis of RNA binding properties in relation to assembly state

    • Investigation of potential physiological relevance to extracellular survival

Understanding any self-assembly properties of P. amoebophila rpmF would be crucial for proper experimental design and interpretation, especially if such behavior represents a biologically relevant feature rather than merely an in vitro artifact.

What future research directions are most promising for advancing our understanding of P. amoebophila rpmF?

Based on current knowledge and the unusual biological characteristics of P. amoebophila, several promising research directions could significantly advance our understanding of its rpmF protein:

1. Structural Biology Approaches:

  • High-resolution structure determination of P. amoebophila rpmF (X-ray crystallography, cryo-EM)

  • Comparative structural analysis with rpmF from pathogenic chlamydiae

  • Investigation of potential structural adaptations related to extracellular activity

  • Characterization of any self-assembly properties similar to those observed in other chlamydial proteins

2. Functional Studies in Extracellular Context:

  • Analysis of rpmF's role in the remarkable extracellular protein synthesis capability of P. amoebophila

  • Investigation of potential modifications or conformational changes during host-free periods

  • Examination of rpmF involvement in stress response during environmental exposure

  • Development of cell-free translation systems based on P. amoebophila components

3. Protein-Protein and Protein-RNA Interaction Mapping:

  • Comprehensive identification of rpmF interaction partners within and outside the ribosome

  • Detailed characterization of rRNA binding sites and specificity determinants

  • Investigation of potential regulatory interactions under different conditions

  • Comparative analysis of interaction networks across chlamydial species

4. Synthetic Biology Applications:

  • Engineering of stabilized ribosomes incorporating P. amoebophila rpmF features

  • Development of extracellular protein expression systems exploiting P. amoebophila's unique capabilities

  • Creation of chimeric ribosomal proteins with enhanced properties for biotechnological applications

  • Exploration of potential antimicrobial targets based on structural insights

5. Environmental and Evolutionary Studies:

  • Investigation of rpmF evolution across environmental and pathogenic chlamydiae

  • Analysis of selective pressures on ribosomal proteins in different host environments

  • Examination of rpmF's potential role in determining host range and adaptation

  • Exploration of horizontal gene transfer involving ribosomal protein genes in chlamydial evolution

These research directions would leverage P. amoebophila's unique biological properties, particularly its remarkable ability to maintain metabolic activity outside host cells , to advance both basic understanding of ribosomal biology and potential applications in biotechnology and medicine.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.